ASX:DVL dorsaVi (DVL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About dorsaVi Stock (ASX:DVL) 30 days 90 days 365 days Advanced Chart Get dorsaVi alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$6.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia. Read More Receive DVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for dorsaVi and its competitors with MarketBeat's FREE daily newsletter. Email Address DVL Stock News HeadlinesdorsaVi Launches AI-Powered Movement Analysis PlatformDecember 13, 2024 | markets.businessinsider.comDorsaVi Eyes Blockchain for Enhanced Data SecurityNovember 20, 2024 | markets.businessinsider.comThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And the media jumped to hasty conclusions. But as usual, there's one huge thing they missed.July 1 at 2:00 AM | Weiss Ratings (Ad)DorsaVi Issues 50 Million Unquoted OptionsNovember 15, 2024 | msn.comDorsaVi Limited Announces New Securities IssuanceNovember 1, 2024 | markets.businessinsider.comdorsaVi Limited Prepares for 2024 Shareholder MeetingOctober 26, 2024 | msn.comdorsaVi Limited Announces Director ResignationOctober 24, 2024 | markets.businessinsider.comdorsaVi Appoints New Chair Amid Leadership ChangesOctober 24, 2024 | markets.businessinsider.comSee More Headlines DVL Stock Analysis - Frequently Asked Questions How were dorsaVi's earnings last quarter? dorsaVi Ltd (ASX:DVL) issued its earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. dorsaVi had a negative net margin of 95.66% and a negative trailing twelve-month return on equity of 102.89%. What other stocks do shareholders of dorsaVi own? Based on aggregate information from My MarketBeat watchlists, some other companies that dorsaVi investors own include Myriad Genetics (MYGN), VMware (VMW), Akers Biosciences (AKER), Alder Biopharmaceuticals (ALDR), Argos Therapeutics (ARGSQ), Aramark (ARMK) and Bellerophon Therapeutics (BLPH). Company Calendar Last Earnings2/28/2019Today7/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolASX:DVL CIKN/A Webwww.dorsavi.com Phone1800 367 728FaxN/AEmployees34Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$1.25 million Net Margins-95.66% Pretax MarginN/A Return on Equity-102.89% Return on Assets-43.41% Debt Debt-to-Equity Ratio18.58 Current Ratio1.87 Quick Ratio0.80 Sales & Book Value Annual SalesA$1.30 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.71 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares669,780,000Free FloatN/AMarket CapA$6.58 million OptionableNot Optionable Beta1.24 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (ASX:DVL) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding dorsaVi Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share dorsaVi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.